🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Piramal Pharma Limited (BOM:543635)
India flag India · Delayed Price · Currency is INR
239.25
-0.15 (-0.06%)
At close: Nov 20, 2026

Piramal Pharma Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, Piramal Pharma stock has a consensus rating of "Strong Buy" and an average price target of ₹262.91. The average 1-year stock price forecast is 9.89% higher than the current stock price, while the lowest is ₹220.00 (-8.05%) and the highest is ₹300.00 (+25.39%).

Price Target: ₹262.91 (+9.89%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price₹220.00₹262.91₹270.00₹300.00
Change-8.05%+9.89%+12.85%+25.39%

Analyst Ratings

The average analyst rating for Piramal Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingNov '25Jan '26Apr '26Jul '26Aug '26Oct '26
Strong Buy678888
Buy222223
Hold000000
Sell111110
Strong Sell000000
Total91011111111

Financial Forecast

Revenue This Year
105.82B
from 88.69B
Increased by 19.31%
Revenue Next Year
120.10B
from 105.82B
Increased by 13.50%
EPS This Year
1.64
from -0.98
EPS Next Year
4.14
from 1.64
Increased by 152.39%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027E
Period EndingMar 31, 2022Mar 31, 2023Mar 31, 2024Mar 31, 2025Mar 31, 2026Mar 31, 2027
Revenue
67.34B70.82B81.71B91.51B88.69B105.82B
Revenue Growth
14.39%5.16%15.39%11.99%-3.08%19.31%
Gross Profit
42.83B41.10B49.09B55.96B52.91B67.87B
Gross Margin
63.60%58.04%60.08%61.15%59.66%64.14%
Operating Income
5.60B-446.50M4.60B6.33B956.90M5.81B
Net Income
3.76B-1.86B178.20M911.30M-3.26B2.29B
EPS
-----0.981.64
Forward PE
-----145.91
Dividend / Share
0.98-0.110.14-0.15
Free Cash Flow
----10.31B-1.68B
No. Analysts
-----11
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.

Revenue Forecast

Revenue202720282029
High107.4B
Avg105.8B
Low104.9B

Revenue Growth

Revenue Growth202720282029
High
21.1%
Avg
19.3%
Low
18.3%

EPS Forecast

EPS202720282029
High3.00
Avg1.64
Low0.87

EPS Growth

EPS Growth202720282029
High-
Avg-
Low-